Global Infectious Disease Testing Instrumentation Market Growth 2026-2032
The global Infectious Disease Testing Instrumentation market size is predicted to grow from US$ 5303 million in 2025 to US$ 7875 million in 2032; it is expected to grow at a CAGR of 5.9% from 2026 to 2032.
Infectious Disease Testing Instrumentation refers to diagnostic instruments and integrated analytical systems used to detect, identify, characterize, or support the diagnosis of infectious diseases caused by viruses, bacteria, fungi, parasites, and other clinically relevant pathogens. The market covers molecular diagnostic instruments using technologies such as PCR and nucleic acid amplification, immunoassay analyzers that detect pathogen antigens or infection-related antibodies, microbiology diagnostic instruments for culture-based identification and susceptibility-related workflows, mass spectrometry-based microbial identification systems, and sequencing-based pathogen detection systems. Products range from fully automated high-throughput laboratory platforms to semi-automated systems, decentralized benchtop analyzers, point-of-care systems, and portable or mobile testing instruments. Core functionality increasingly combines sample preparation, target amplification or biochemical reaction, signal detection, data interpretation, and laboratory information connectivity within integrated workflows. Infectious Disease Testing Instrumentation is primarily deployed in hospitals and clinics, clinical diagnostic laboratories, independent laboratories, public-health and disease-control laboratories, blood centers, primary-care and point-of-care settings, quarantine institutions, and research organizations, supporting routine diagnosis, outbreak response, pathogen surveillance, infection control, and antimicrobial stewardship.
Molecular diagnostics remain central to high-value infectious disease testing workflows
Syndromic multiplex testing is accelerating rapid decentralized infectious disease diagnosis
High-throughput laboratories increasingly prioritize automation workflow integration and random access
Antimicrobial resistance strengthens demand for rapid pathogen identification and characterization
The midstream segment integrates instrument engineering, assay development, software, regulatory validation, manufacturing, and after-sales technical service. Value creation increasingly comes from the combined instrument-and-assay ecosystem rather than the hardware alone: laboratories evaluate not only acquisition cost, but also assay menu breadth, throughput, turnaround time, automation level, reagent consumption, labor requirements, data connectivity, and service capability. Downstream demand is generated primarily by clinical laboratories, hospitals, public-health systems, blood-testing institutions, decentralized testing sites, and research organizations. As installed platforms accumulate, recurring demand for dedicated assays, consumables, quality controls, software support, and maintenance becomes an important component of lifecycle economics.
From the automation, throughput, and deployment perspectives, market demand is becoming increasingly differentiated rather than converging around a single instrument configuration. Fully automated high-throughput systems are primarily suited to large hospitals and central laboratories with continuous sample flows, whereas medium- and low-throughput systems emphasize flexibility and utilization efficiency. Decentralized benchtop, point-of-care, and portable systems compete primarily on ease of operation, short turnaround time, limited hands-on requirements, and the ability to provide results closer to the patient. This segmentation supports parallel development of large integrated laboratory automation systems and compact rapid diagnostic platforms rather than direct substitution between the two categories.
Asia-Pacific represents a major area of incremental opportunity due to its large patient population, expanding diagnostic infrastructure, diverse infectious disease burden, and growing local manufacturing capability. Market development varies considerably between mature laboratory markets and countries where access to advanced molecular testing remains concentrated in major hospitals and reference laboratories. China is also developing a broader domestic supplier base across molecular diagnostics, immunoassay systems, and rapid testing platforms. In Latin America, the Middle East, and Africa, demand is more strongly influenced by public-health programs, infectious disease control priorities, affordability, reagent availability, and the ability to operate instruments under decentralized conditions. Rapid molecular testing for tuberculosis and other high-burden infectious diseases remains particularly relevant to diagnostic-network development in many emerging markets.
This Insight Report provides a comprehensive analysis of the global Infectious Disease Testing Instrumentation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infectious Disease Testing Instrumentation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infectious Disease Testing Instrumentation market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Disease Testing Instrumentation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Disease Testing Instrumentation.
This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease Testing Instrumentation market by product type, application, key manufacturers and key regions and countries.
Infectious Disease Testing Instrumentation refers to diagnostic instruments and integrated analytical systems used to detect, identify, characterize, or support the diagnosis of infectious diseases caused by viruses, bacteria, fungi, parasites, and other clinically relevant pathogens. The market covers molecular diagnostic instruments using technologies such as PCR and nucleic acid amplification, immunoassay analyzers that detect pathogen antigens or infection-related antibodies, microbiology diagnostic instruments for culture-based identification and susceptibility-related workflows, mass spectrometry-based microbial identification systems, and sequencing-based pathogen detection systems. Products range from fully automated high-throughput laboratory platforms to semi-automated systems, decentralized benchtop analyzers, point-of-care systems, and portable or mobile testing instruments. Core functionality increasingly combines sample preparation, target amplification or biochemical reaction, signal detection, data interpretation, and laboratory information connectivity within integrated workflows. Infectious Disease Testing Instrumentation is primarily deployed in hospitals and clinics, clinical diagnostic laboratories, independent laboratories, public-health and disease-control laboratories, blood centers, primary-care and point-of-care settings, quarantine institutions, and research organizations, supporting routine diagnosis, outbreak response, pathogen surveillance, infection control, and antimicrobial stewardship.
Key Findings
Infectious disease testing is shifting toward integrated automated diagnostic platformsMolecular diagnostics remain central to high-value infectious disease testing workflows
Syndromic multiplex testing is accelerating rapid decentralized infectious disease diagnosis
High-throughput laboratories increasingly prioritize automation workflow integration and random access
Antimicrobial resistance strengthens demand for rapid pathogen identification and characterization
Market Trends
The technology direction of Infectious Disease Testing Instrumentation is moving from individual analytical steps toward integrated, automated, sample-to-answer workflows. High-throughput central laboratories increasingly favor systems capable of continuous loading, random access, broad assay consolidation, reduced manual intervention, and connectivity with laboratory information systems, while decentralized settings are adopting compact systems that shorten the distance between specimen collection and clinical decision-making. At the same time, infectious disease testing is evolving from single-pathogen detection toward multiplex and syndromic approaches that test multiple clinically relevant pathogens in one workflow, particularly for respiratory, gastrointestinal, central nervous system, and other infections with overlapping symptoms. Another important direction is the integration of pathogen detection with antimicrobial-resistance information, improving the clinical value of diagnostic results beyond simple positive or negative identification. Sequencing-based technologies are also gradually entering specialized diagnostic workflows, especially where conventional assays cannot provide sufficient resolution or where drug-resistance characterization is required; updated tuberculosis diagnostic guidance has already incorporated targeted next-generation sequencing into relevant diagnostic pathways.Market Dynamics
Drivers
Demand for Infectious Disease Testing Instrumentation is fundamentally supported by the continuing need for earlier pathogen identification, faster clinical decision-making, infection-control management, disease surveillance, and more precise antimicrobial use. Molecular testing has shortened diagnostic turnaround for diseases that historically depended on slower culture or microscopy workflows, while automated platforms reduce hands-on operations and enable laboratories to process broader test menus with limited technical resources. Antimicrobial resistance is creating an additional structural driver because healthcare systems increasingly require diagnostic information that can support appropriate therapy selection rather than relying solely on empirical treatment. International initiatives to strengthen bacteriology, mycology, resistance testing, and laboratory capacity are also reinforcing the strategic importance of infectious disease diagnostics across different levels of healthcare systems.Restraints
Market expansion is constrained by the relatively high acquisition and lifecycle cost of advanced diagnostic systems, particularly where platforms require dedicated cartridges, reagents, maintenance, calibration, software, and quality-control procedures. Laboratories must also balance instrument throughput with actual testing volume, making high-capacity automation economically less attractive in low-volume settings. Regulatory approval of instruments and individual assays, validation of new specimen types, laboratory quality requirements, and differences in reimbursement or public procurement can extend commercialization cycles. In addition, different technologies are not interchangeable: molecular diagnostics, immunoassays, culture-based microbiology, mass spectrometry, and sequencing each address different clinical questions, requiring laboratories to maintain multiple complementary workflows rather than replacing all testing with a single platform.Opportunities
The most attractive opportunities are emerging at the intersection of rapid testing, automation, decentralization, and broader assay menus. Compact molecular systems can extend advanced testing from central laboratories toward emergency departments, smaller hospitals, outpatient facilities, and other near-patient settings, while modular systems allow laboratories to expand capacity as test volumes increase. Multiplex syndromic testing provides another opportunity by consolidating multiple pathogen targets into a single clinical workflow and reducing sequential testing. The increasing importance of antimicrobial resistance creates room for platforms that connect pathogen identification with resistance-marker detection or susceptibility-related information. In parallel, sequencing-based pathogen detection may expand in specialized applications such as complex infections, emerging pathogens, epidemiological surveillance, and resistance characterization as workflows become more standardized and operationally accessible.Challenges
A major long-term challenge is maintaining diagnostic performance as pathogens evolve and new infectious threats emerge. Manufacturers must continually update assay menus, databases, software, primers, probes, and interpretive algorithms while managing regulatory requirements across different jurisdictions. Laboratories also face interoperability challenges when integrating multiple instruments with information systems and existing sample-management workflows. For decentralized systems, ease of operation must be balanced against analytical reliability, contamination control, quality assurance, and operator training. Commercial success therefore depends not only on instrument performance but also on assay availability, reagent continuity, technical support, installed-base servicing, regulatory execution, and the ability to respond rapidly to changing epidemiological demand.Industry Chain Analysis
The upstream industry chain of Infectious Disease Testing Instrumentation combines precision instrumentation components and diagnostic consumables. Key inputs include optical and fluorescence detection modules, thermal-control and amplification components, fluidics and microfluidic structures, pumps and valves, sensors, electronic control systems, automation modules, mass-spectrometry components, sequencing-related modules, and specialized software. Diagnostic performance also depends on biological materials such as enzymes, primers, probes, antibodies, antigens, calibration materials, controls, culture media, biochemical substrates, and disposable cartridges or reaction vessels. Consequently, upstream quality consistency, biological raw-material performance, and supply continuity have a direct impact on instrument reliability and assay reproducibility.The midstream segment integrates instrument engineering, assay development, software, regulatory validation, manufacturing, and after-sales technical service. Value creation increasingly comes from the combined instrument-and-assay ecosystem rather than the hardware alone: laboratories evaluate not only acquisition cost, but also assay menu breadth, throughput, turnaround time, automation level, reagent consumption, labor requirements, data connectivity, and service capability. Downstream demand is generated primarily by clinical laboratories, hospitals, public-health systems, blood-testing institutions, decentralized testing sites, and research organizations. As installed platforms accumulate, recurring demand for dedicated assays, consumables, quality controls, software support, and maintenance becomes an important component of lifecycle economics.
Segment Insights
By detection technology, molecular diagnostic instruments occupy the most technologically intensive part of Infectious Disease Testing Instrumentation and are particularly important for rapid detection of viral, bacterial, and other pathogen nucleic acids. Fully integrated PCR platforms are increasingly combining extraction, amplification, detection, and interpretation, while multiplex systems extend the number of pathogens that can be evaluated in one workflow. Immunoassay analyzers remain important for antigen and antibody testing and are especially relevant to high-volume serology and routine laboratory workflows. Microbiology diagnostic instruments retain an essential role in culture, microbial identification, and antimicrobial susceptibility workflows, while mass spectrometry-based identification improves the speed of species-level identification after culture. Sequencing-based systems represent a more specialized but strategically important segment for difficult-to-characterize pathogens and resistance analysis.From the automation, throughput, and deployment perspectives, market demand is becoming increasingly differentiated rather than converging around a single instrument configuration. Fully automated high-throughput systems are primarily suited to large hospitals and central laboratories with continuous sample flows, whereas medium- and low-throughput systems emphasize flexibility and utilization efficiency. Decentralized benchtop, point-of-care, and portable systems compete primarily on ease of operation, short turnaround time, limited hands-on requirements, and the ability to provide results closer to the patient. This segmentation supports parallel development of large integrated laboratory automation systems and compact rapid diagnostic platforms rather than direct substitution between the two categories.
Downstream Market Opportunities
Hospitals and clinical diagnostic laboratories remain the core downstream users because infectious disease testing is directly linked to patient triage, treatment selection, isolation decisions, infection prevention, and antimicrobial management. The strongest incremental opportunities are developing where diagnostic results have high time sensitivity, including emergency care, respiratory infections, bloodstream and severe infections, gastrointestinal infections, sexually transmitted infections, and healthcare-associated infections. Public-health and disease-control laboratories create additional demand for outbreak confirmation and surveillance, while blood centers require high-reliability infectious disease screening. Decentralized healthcare settings represent an important emerging application because compact molecular and immunological systems can transfer selected testing capabilities closer to primary care and patients while maintaining standardized analytical workflows.Regional Insights
North America remains one of the most mature high-value markets for Infectious Disease Testing Instrumentation, characterized by broad adoption of automated molecular diagnostics, syndromic testing, laboratory consolidation, and decentralized rapid-testing platforms. Europe also has an established clinical laboratory infrastructure, although procurement, reimbursement, and laboratory organization differ materially between countries. Both regions increasingly emphasize workflow automation, assay consolidation, antimicrobial stewardship, and integration of diagnostic instruments with laboratory information systems. The availability of platforms spanning high-throughput central laboratories and near-patient testing illustrates the diversified demand structure of mature markets.Asia-Pacific represents a major area of incremental opportunity due to its large patient population, expanding diagnostic infrastructure, diverse infectious disease burden, and growing local manufacturing capability. Market development varies considerably between mature laboratory markets and countries where access to advanced molecular testing remains concentrated in major hospitals and reference laboratories. China is also developing a broader domestic supplier base across molecular diagnostics, immunoassay systems, and rapid testing platforms. In Latin America, the Middle East, and Africa, demand is more strongly influenced by public-health programs, infectious disease control priorities, affordability, reagent availability, and the ability to operate instruments under decentralized conditions. Rapid molecular testing for tuberculosis and other high-burden infectious diseases remains particularly relevant to diagnostic-network development in many emerging markets.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Infectious Disease Testing Instrumentation Industry Forecast” looks at past sales and reviews total world Infectious Disease Testing Instrumentation sales in 2025, providing a comprehensive analysis by region and market sector of projected Infectious Disease Testing Instrumentation sales for 2026 through 2032. With Infectious Disease Testing Instrumentation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Disease Testing Instrumentation industry.This Insight Report provides a comprehensive analysis of the global Infectious Disease Testing Instrumentation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infectious Disease Testing Instrumentation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infectious Disease Testing Instrumentation market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Disease Testing Instrumentation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Disease Testing Instrumentation.
This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease Testing Instrumentation market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Molecular Diagnostic Instruments
- Immunoassay Analyzers
- Microbiology Diagnostic Instruments
- Other
Segmentation by Automation Level:
- Fully Automated Systems
- Semi-Automated Systems
Segmentation by Testing Throughput:
- Low-throughput Systems
- Medium-throughput Systems
- High-throughput Systems
Segmentation by Application:
- Hospital & Clinic
- Laboratory
- Other
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche Diagnostics
- Abbott Laboratories
- BD
- bioM?rieux
- Danaher
- QIAGEN
- Hologic
- DiaSorin
- QuidelOrtho
- Siemens Healthineers
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Sansure Biotech
- Daan Gene
- Jiangsu Bioperfectus
- Autobio Diagnostics
- Snibe Diagnostic
- Guangzhou Wondfo Biotech
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Infectious Disease Testing Instrumentation market?
- What factors are driving Infectious Disease Testing Instrumentation market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Infectious Disease Testing Instrumentation market opportunities vary by end market size?
- How does Infectious Disease Testing Instrumentation break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infectious Disease Testing Instrumentation Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Infectious Disease Testing Instrumentation by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Infectious Disease Testing Instrumentation by Country/Region, 2021, 2025 & 2032
2.2 Infectious Disease Testing Instrumentation Segment by Type
2.2.1 Molecular Diagnostic Instruments
2.2.2 Immunoassay Analyzers
2.2.3 Microbiology Diagnostic Instruments
2.2.4 Other
2.2.5 Infectious Disease Testing Instrumentation Sales by Type
2.2.5.1 Global Infectious Disease Testing Instrumentation Sales Market Share by Type (2021-2026)
2.2.5.2 Global Infectious Disease Testing Instrumentation Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Infectious Disease Testing Instrumentation Sale Price by Type (2021-2026)
2.3 Infectious Disease Testing Instrumentation Segment by Automation Level
2.3.1 Fully Automated Systems
2.3.2 Semi-Automated Systems
2.3.3 Infectious Disease Testing Instrumentation Sales by Automation Level
2.3.3.1 Global Infectious Disease Testing Instrumentation Sales Market Share by Automation Level (2021-2026)
2.3.3.2 Global Infectious Disease Testing Instrumentation Revenue and Market Share by Automation Level (2021-2026)
2.3.3.3 Global Infectious Disease Testing Instrumentation Sale Price by Automation Level (2021-2026)
2.4 Infectious Disease Testing Instrumentation Segment by Testing Throughput
2.4.1 Low-throughput Systems
2.4.2 Medium-throughput Systems
2.4.3 High-throughput Systems
2.4.4 Infectious Disease Testing Instrumentation Sales by Testing Throughput
2.4.4.1 Global Infectious Disease Testing Instrumentation Sales Market Share by Testing Throughput (2021-2026)
2.4.4.2 Global Infectious Disease Testing Instrumentation Revenue and Market Share by Testing Throughput (2021-2026)
2.4.4.3 Global Infectious Disease Testing Instrumentation Sale Price by Testing Throughput (2021-2026)
2.5 Infectious Disease Testing Instrumentation Segment by Application
2.5.1 Hospital & Clinic
2.5.2 Laboratory
2.5.3 Other
2.5.4 Infectious Disease Testing Instrumentation Sales by Application
2.5.4.1 Global Infectious Disease Testing Instrumentation Sale Market Share by Application (2021-2026)
2.5.4.2 Global Infectious Disease Testing Instrumentation Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Infectious Disease Testing Instrumentation Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Infectious Disease Testing Instrumentation Breakdown Data by Company
3.1.1 Global Infectious Disease Testing Instrumentation Annual Sales by Company (2021-2026)
3.1.2 Global Infectious Disease Testing Instrumentation Sales Market Share by Company (2021-2026)
3.2 Global Infectious Disease Testing Instrumentation Annual Revenue by Company (2021-2026)
3.2.1 Global Infectious Disease Testing Instrumentation Revenue by Company (2021-2026)
3.2.2 Global Infectious Disease Testing Instrumentation Revenue Market Share by Company (2021-2026)
3.3 Global Infectious Disease Testing Instrumentation Sale Price by Company
3.4 Key Manufacturers Infectious Disease Testing Instrumentation Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Infectious Disease Testing Instrumentation Product Location Distribution
3.4.2 Players Infectious Disease Testing Instrumentation Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INFECTIOUS DISEASE TESTING INSTRUMENTATION BY GEOGRAPHIC REGION
4.1 World Historic Infectious Disease Testing Instrumentation Market Size by Geographic Region (2021-2026)
4.1.1 Global Infectious Disease Testing Instrumentation Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Infectious Disease Testing Instrumentation Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Infectious Disease Testing Instrumentation Market Size by Country/Region (2021-2026)
4.2.1 Global Infectious Disease Testing Instrumentation Annual Sales by Country/Region (2021-2026)
4.2.2 Global Infectious Disease Testing Instrumentation Annual Revenue by Country/Region (2021-2026)
4.3 Americas Infectious Disease Testing Instrumentation Sales Growth
4.4 APAC Infectious Disease Testing Instrumentation Sales Growth
4.5 Europe Infectious Disease Testing Instrumentation Sales Growth
4.6 Middle East & Africa Infectious Disease Testing Instrumentation Sales Growth
5 AMERICAS
5.1 Americas Infectious Disease Testing Instrumentation Sales by Country
5.1.1 Americas Infectious Disease Testing Instrumentation Sales by Country (2021-2026)
5.1.2 Americas Infectious Disease Testing Instrumentation Revenue by Country (2021-2026)
5.2 Americas Infectious Disease Testing Instrumentation Sales by Type (2021-2026)
5.3 Americas Infectious Disease Testing Instrumentation Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Disease Testing Instrumentation Sales by Region
6.1.1 APAC Infectious Disease Testing Instrumentation Sales by Region (2021-2026)
6.1.2 APAC Infectious Disease Testing Instrumentation Revenue by Region (2021-2026)
6.2 APAC Infectious Disease Testing Instrumentation Sales by Type (2021-2026)
6.3 APAC Infectious Disease Testing Instrumentation Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Infectious Disease Testing Instrumentation by Country
7.1.1 Europe Infectious Disease Testing Instrumentation Sales by Country (2021-2026)
7.1.2 Europe Infectious Disease Testing Instrumentation Revenue by Country (2021-2026)
7.2 Europe Infectious Disease Testing Instrumentation Sales by Type (2021-2026)
7.3 Europe Infectious Disease Testing Instrumentation Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infectious Disease Testing Instrumentation by Country
8.1.1 Middle East & Africa Infectious Disease Testing Instrumentation Sales by Country (2021-2026)
8.1.2 Middle East & Africa Infectious Disease Testing Instrumentation Revenue by Country (2021-2026)
8.2 Middle East & Africa Infectious Disease Testing Instrumentation Sales by Type (2021-2026)
8.3 Middle East & Africa Infectious Disease Testing Instrumentation Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Infectious Disease Testing Instrumentation
10.3 Manufacturing Process Analysis of Infectious Disease Testing Instrumentation
10.4 Industry Chain Structure of Infectious Disease Testing Instrumentation
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Infectious Disease Testing Instrumentation Distributors
11.3 Infectious Disease Testing Instrumentation Customer
12 WORLD FORECAST REVIEW FOR INFECTIOUS DISEASE TESTING INSTRUMENTATION BY GEOGRAPHIC REGION
12.1 Global Infectious Disease Testing Instrumentation Market Size Forecast by Region
12.1.1 Global Infectious Disease Testing Instrumentation Forecast by Region (2027-2032)
12.1.2 Global Infectious Disease Testing Instrumentation Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Infectious Disease Testing Instrumentation Forecast by Type (2027-2032)
12.7 Global Infectious Disease Testing Instrumentation Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Company Information
13.1.2 Roche Diagnostics Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.1.3 Roche Diagnostics Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Roche Diagnostics Main Business Overview
13.1.5 Roche Diagnostics Latest Developments
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Information
13.2.2 Abbott Laboratories Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.2.3 Abbott Laboratories Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Abbott Laboratories Main Business Overview
13.2.5 Abbott Laboratories Latest Developments
13.3 BD
13.3.1 BD Company Information
13.3.2 BD Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.3.3 BD Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 BD Main Business Overview
13.3.5 BD Latest Developments
13.4 bioM?rieux
13.4.1 bioM?rieux Company Information
13.4.2 bioM?rieux Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.4.3 bioM?rieux Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 bioM?rieux Main Business Overview
13.4.5 bioM?rieux Latest Developments
13.5 Danaher
13.5.1 Danaher Company Information
13.5.2 Danaher Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.5.3 Danaher Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Danaher Main Business Overview
13.5.5 Danaher Latest Developments
13.6 QIAGEN
13.6.1 QIAGEN Company Information
13.6.2 QIAGEN Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.6.3 QIAGEN Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 QIAGEN Main Business Overview
13.6.5 QIAGEN Latest Developments
13.7 Hologic
13.7.1 Hologic Company Information
13.7.2 Hologic Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.7.3 Hologic Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Hologic Main Business Overview
13.7.5 Hologic Latest Developments
13.8 DiaSorin
13.8.1 DiaSorin Company Information
13.8.2 DiaSorin Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.8.3 DiaSorin Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 DiaSorin Main Business Overview
13.8.5 DiaSorin Latest Developments
13.9 QuidelOrtho
13.9.1 QuidelOrtho Company Information
13.9.2 QuidelOrtho Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.9.3 QuidelOrtho Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 QuidelOrtho Main Business Overview
13.9.5 QuidelOrtho Latest Developments
13.10 Siemens Healthineers
13.10.1 Siemens Healthineers Company Information
13.10.2 Siemens Healthineers Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.10.3 Siemens Healthineers Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Siemens Healthineers Main Business Overview
13.10.5 Siemens Healthineers Latest Developments
13.11 Thermo Fisher Scientific
13.11.1 Thermo Fisher Scientific Company Information
13.11.2 Thermo Fisher Scientific Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.11.3 Thermo Fisher Scientific Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Thermo Fisher Scientific Main Business Overview
13.11.5 Thermo Fisher Scientific Latest Developments
13.12 Bio-Rad Laboratories
13.12.1 Bio-Rad Laboratories Company Information
13.12.2 Bio-Rad Laboratories Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.12.3 Bio-Rad Laboratories Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Bio-Rad Laboratories Main Business Overview
13.12.5 Bio-Rad Laboratories Latest Developments
13.13 Sansure Biotech
13.13.1 Sansure Biotech Company Information
13.13.2 Sansure Biotech Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.13.3 Sansure Biotech Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Sansure Biotech Main Business Overview
13.13.5 Sansure Biotech Latest Developments
13.14 Daan Gene
13.14.1 Daan Gene Company Information
13.14.2 Daan Gene Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.14.3 Daan Gene Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Daan Gene Main Business Overview
13.14.5 Daan Gene Latest Developments
13.15 Jiangsu Bioperfectus
13.15.1 Jiangsu Bioperfectus Company Information
13.15.2 Jiangsu Bioperfectus Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.15.3 Jiangsu Bioperfectus Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Jiangsu Bioperfectus Main Business Overview
13.15.5 Jiangsu Bioperfectus Latest Developments
13.16 Autobio Diagnostics
13.16.1 Autobio Diagnostics Company Information
13.16.2 Autobio Diagnostics Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.16.3 Autobio Diagnostics Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Autobio Diagnostics Main Business Overview
13.16.5 Autobio Diagnostics Latest Developments
13.17 Snibe Diagnostic
13.17.1 Snibe Diagnostic Company Information
13.17.2 Snibe Diagnostic Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.17.3 Snibe Diagnostic Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Snibe Diagnostic Main Business Overview
13.17.5 Snibe Diagnostic Latest Developments
13.18 Guangzhou Wondfo Biotech
13.18.1 Guangzhou Wondfo Biotech Company Information
13.18.2 Guangzhou Wondfo Biotech Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.18.3 Guangzhou Wondfo Biotech Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Guangzhou Wondfo Biotech Main Business Overview
13.18.5 Guangzhou Wondfo Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infectious Disease Testing Instrumentation Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Infectious Disease Testing Instrumentation by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Infectious Disease Testing Instrumentation by Country/Region, 2021, 2025 & 2032
2.2 Infectious Disease Testing Instrumentation Segment by Type
2.2.1 Molecular Diagnostic Instruments
2.2.2 Immunoassay Analyzers
2.2.3 Microbiology Diagnostic Instruments
2.2.4 Other
2.2.5 Infectious Disease Testing Instrumentation Sales by Type
2.2.5.1 Global Infectious Disease Testing Instrumentation Sales Market Share by Type (2021-2026)
2.2.5.2 Global Infectious Disease Testing Instrumentation Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Infectious Disease Testing Instrumentation Sale Price by Type (2021-2026)
2.3 Infectious Disease Testing Instrumentation Segment by Automation Level
2.3.1 Fully Automated Systems
2.3.2 Semi-Automated Systems
2.3.3 Infectious Disease Testing Instrumentation Sales by Automation Level
2.3.3.1 Global Infectious Disease Testing Instrumentation Sales Market Share by Automation Level (2021-2026)
2.3.3.2 Global Infectious Disease Testing Instrumentation Revenue and Market Share by Automation Level (2021-2026)
2.3.3.3 Global Infectious Disease Testing Instrumentation Sale Price by Automation Level (2021-2026)
2.4 Infectious Disease Testing Instrumentation Segment by Testing Throughput
2.4.1 Low-throughput Systems
2.4.2 Medium-throughput Systems
2.4.3 High-throughput Systems
2.4.4 Infectious Disease Testing Instrumentation Sales by Testing Throughput
2.4.4.1 Global Infectious Disease Testing Instrumentation Sales Market Share by Testing Throughput (2021-2026)
2.4.4.2 Global Infectious Disease Testing Instrumentation Revenue and Market Share by Testing Throughput (2021-2026)
2.4.4.3 Global Infectious Disease Testing Instrumentation Sale Price by Testing Throughput (2021-2026)
2.5 Infectious Disease Testing Instrumentation Segment by Application
2.5.1 Hospital & Clinic
2.5.2 Laboratory
2.5.3 Other
2.5.4 Infectious Disease Testing Instrumentation Sales by Application
2.5.4.1 Global Infectious Disease Testing Instrumentation Sale Market Share by Application (2021-2026)
2.5.4.2 Global Infectious Disease Testing Instrumentation Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Infectious Disease Testing Instrumentation Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Infectious Disease Testing Instrumentation Breakdown Data by Company
3.1.1 Global Infectious Disease Testing Instrumentation Annual Sales by Company (2021-2026)
3.1.2 Global Infectious Disease Testing Instrumentation Sales Market Share by Company (2021-2026)
3.2 Global Infectious Disease Testing Instrumentation Annual Revenue by Company (2021-2026)
3.2.1 Global Infectious Disease Testing Instrumentation Revenue by Company (2021-2026)
3.2.2 Global Infectious Disease Testing Instrumentation Revenue Market Share by Company (2021-2026)
3.3 Global Infectious Disease Testing Instrumentation Sale Price by Company
3.4 Key Manufacturers Infectious Disease Testing Instrumentation Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Infectious Disease Testing Instrumentation Product Location Distribution
3.4.2 Players Infectious Disease Testing Instrumentation Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INFECTIOUS DISEASE TESTING INSTRUMENTATION BY GEOGRAPHIC REGION
4.1 World Historic Infectious Disease Testing Instrumentation Market Size by Geographic Region (2021-2026)
4.1.1 Global Infectious Disease Testing Instrumentation Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Infectious Disease Testing Instrumentation Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Infectious Disease Testing Instrumentation Market Size by Country/Region (2021-2026)
4.2.1 Global Infectious Disease Testing Instrumentation Annual Sales by Country/Region (2021-2026)
4.2.2 Global Infectious Disease Testing Instrumentation Annual Revenue by Country/Region (2021-2026)
4.3 Americas Infectious Disease Testing Instrumentation Sales Growth
4.4 APAC Infectious Disease Testing Instrumentation Sales Growth
4.5 Europe Infectious Disease Testing Instrumentation Sales Growth
4.6 Middle East & Africa Infectious Disease Testing Instrumentation Sales Growth
5 AMERICAS
5.1 Americas Infectious Disease Testing Instrumentation Sales by Country
5.1.1 Americas Infectious Disease Testing Instrumentation Sales by Country (2021-2026)
5.1.2 Americas Infectious Disease Testing Instrumentation Revenue by Country (2021-2026)
5.2 Americas Infectious Disease Testing Instrumentation Sales by Type (2021-2026)
5.3 Americas Infectious Disease Testing Instrumentation Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Disease Testing Instrumentation Sales by Region
6.1.1 APAC Infectious Disease Testing Instrumentation Sales by Region (2021-2026)
6.1.2 APAC Infectious Disease Testing Instrumentation Revenue by Region (2021-2026)
6.2 APAC Infectious Disease Testing Instrumentation Sales by Type (2021-2026)
6.3 APAC Infectious Disease Testing Instrumentation Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Infectious Disease Testing Instrumentation by Country
7.1.1 Europe Infectious Disease Testing Instrumentation Sales by Country (2021-2026)
7.1.2 Europe Infectious Disease Testing Instrumentation Revenue by Country (2021-2026)
7.2 Europe Infectious Disease Testing Instrumentation Sales by Type (2021-2026)
7.3 Europe Infectious Disease Testing Instrumentation Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infectious Disease Testing Instrumentation by Country
8.1.1 Middle East & Africa Infectious Disease Testing Instrumentation Sales by Country (2021-2026)
8.1.2 Middle East & Africa Infectious Disease Testing Instrumentation Revenue by Country (2021-2026)
8.2 Middle East & Africa Infectious Disease Testing Instrumentation Sales by Type (2021-2026)
8.3 Middle East & Africa Infectious Disease Testing Instrumentation Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Infectious Disease Testing Instrumentation
10.3 Manufacturing Process Analysis of Infectious Disease Testing Instrumentation
10.4 Industry Chain Structure of Infectious Disease Testing Instrumentation
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Infectious Disease Testing Instrumentation Distributors
11.3 Infectious Disease Testing Instrumentation Customer
12 WORLD FORECAST REVIEW FOR INFECTIOUS DISEASE TESTING INSTRUMENTATION BY GEOGRAPHIC REGION
12.1 Global Infectious Disease Testing Instrumentation Market Size Forecast by Region
12.1.1 Global Infectious Disease Testing Instrumentation Forecast by Region (2027-2032)
12.1.2 Global Infectious Disease Testing Instrumentation Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Infectious Disease Testing Instrumentation Forecast by Type (2027-2032)
12.7 Global Infectious Disease Testing Instrumentation Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Company Information
13.1.2 Roche Diagnostics Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.1.3 Roche Diagnostics Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Roche Diagnostics Main Business Overview
13.1.5 Roche Diagnostics Latest Developments
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Information
13.2.2 Abbott Laboratories Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.2.3 Abbott Laboratories Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Abbott Laboratories Main Business Overview
13.2.5 Abbott Laboratories Latest Developments
13.3 BD
13.3.1 BD Company Information
13.3.2 BD Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.3.3 BD Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 BD Main Business Overview
13.3.5 BD Latest Developments
13.4 bioM?rieux
13.4.1 bioM?rieux Company Information
13.4.2 bioM?rieux Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.4.3 bioM?rieux Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 bioM?rieux Main Business Overview
13.4.5 bioM?rieux Latest Developments
13.5 Danaher
13.5.1 Danaher Company Information
13.5.2 Danaher Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.5.3 Danaher Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Danaher Main Business Overview
13.5.5 Danaher Latest Developments
13.6 QIAGEN
13.6.1 QIAGEN Company Information
13.6.2 QIAGEN Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.6.3 QIAGEN Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 QIAGEN Main Business Overview
13.6.5 QIAGEN Latest Developments
13.7 Hologic
13.7.1 Hologic Company Information
13.7.2 Hologic Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.7.3 Hologic Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Hologic Main Business Overview
13.7.5 Hologic Latest Developments
13.8 DiaSorin
13.8.1 DiaSorin Company Information
13.8.2 DiaSorin Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.8.3 DiaSorin Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 DiaSorin Main Business Overview
13.8.5 DiaSorin Latest Developments
13.9 QuidelOrtho
13.9.1 QuidelOrtho Company Information
13.9.2 QuidelOrtho Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.9.3 QuidelOrtho Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 QuidelOrtho Main Business Overview
13.9.5 QuidelOrtho Latest Developments
13.10 Siemens Healthineers
13.10.1 Siemens Healthineers Company Information
13.10.2 Siemens Healthineers Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.10.3 Siemens Healthineers Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Siemens Healthineers Main Business Overview
13.10.5 Siemens Healthineers Latest Developments
13.11 Thermo Fisher Scientific
13.11.1 Thermo Fisher Scientific Company Information
13.11.2 Thermo Fisher Scientific Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.11.3 Thermo Fisher Scientific Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Thermo Fisher Scientific Main Business Overview
13.11.5 Thermo Fisher Scientific Latest Developments
13.12 Bio-Rad Laboratories
13.12.1 Bio-Rad Laboratories Company Information
13.12.2 Bio-Rad Laboratories Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.12.3 Bio-Rad Laboratories Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Bio-Rad Laboratories Main Business Overview
13.12.5 Bio-Rad Laboratories Latest Developments
13.13 Sansure Biotech
13.13.1 Sansure Biotech Company Information
13.13.2 Sansure Biotech Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.13.3 Sansure Biotech Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Sansure Biotech Main Business Overview
13.13.5 Sansure Biotech Latest Developments
13.14 Daan Gene
13.14.1 Daan Gene Company Information
13.14.2 Daan Gene Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.14.3 Daan Gene Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Daan Gene Main Business Overview
13.14.5 Daan Gene Latest Developments
13.15 Jiangsu Bioperfectus
13.15.1 Jiangsu Bioperfectus Company Information
13.15.2 Jiangsu Bioperfectus Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.15.3 Jiangsu Bioperfectus Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Jiangsu Bioperfectus Main Business Overview
13.15.5 Jiangsu Bioperfectus Latest Developments
13.16 Autobio Diagnostics
13.16.1 Autobio Diagnostics Company Information
13.16.2 Autobio Diagnostics Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.16.3 Autobio Diagnostics Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Autobio Diagnostics Main Business Overview
13.16.5 Autobio Diagnostics Latest Developments
13.17 Snibe Diagnostic
13.17.1 Snibe Diagnostic Company Information
13.17.2 Snibe Diagnostic Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.17.3 Snibe Diagnostic Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Snibe Diagnostic Main Business Overview
13.17.5 Snibe Diagnostic Latest Developments
13.18 Guangzhou Wondfo Biotech
13.18.1 Guangzhou Wondfo Biotech Company Information
13.18.2 Guangzhou Wondfo Biotech Infectious Disease Testing Instrumentation Product Portfolios and Specifications
13.18.3 Guangzhou Wondfo Biotech Infectious Disease Testing Instrumentation Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Guangzhou Wondfo Biotech Main Business Overview
13.18.5 Guangzhou Wondfo Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Infectious Disease Testing Instrumentation Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Infectious Disease Testing Instrumentation Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Molecular Diagnostic Instruments
Table 4. Major Players of Immunoassay Analyzers
Table 5. Major Players of Microbiology Diagnostic Instruments
Table 6. Major Players of Other
Table 7. Global Infectious Disease Testing Instrumentation Sales by Type (2021-2026) & (K Units)
Table 8. Global Infectious Disease Testing Instrumentation Sales Market Share by Type (2021-2026)
Table 9. Global Infectious Disease Testing Instrumentation Revenue by Type (2021-2026) & ($ million)
Table 10. Global Infectious Disease Testing Instrumentation Revenue Market Share by Type (2021-2026)
Table 11. Global Infectious Disease Testing Instrumentation Sale Price by Type (2021-2026) & (K USD/Unit)
Table 12. Major Players of Fully Automated Systems
Table 13. Major Players of Semi-Automated Systems
Table 14. Global Infectious Disease Testing Instrumentation Sales by Automation Level (2021-2026) & (K Units)
Table 15. Global Infectious Disease Testing Instrumentation Sales Market Share by Automation Level (2021-2026)
Table 16. Global Infectious Disease Testing Instrumentation Revenue by Automation Level (2021-2026) & ($ million)
Table 17. Global Infectious Disease Testing Instrumentation Revenue Market Share by Automation Level (2021-2026)
Table 18. Global Infectious Disease Testing Instrumentation Sale Price by Automation Level (2021-2026) & (K USD/Unit)
Table 19. Major Players of Low-throughput Systems
Table 20. Major Players of Medium-throughput Systems
Table 21. Major Players of High-throughput Systems
Table 22. Global Infectious Disease Testing Instrumentation Sales by Testing Throughput (2021-2026) & (K Units)
Table 23. Global Infectious Disease Testing Instrumentation Sales Market Share by Testing Throughput (2021-2026)
Table 24. Global Infectious Disease Testing Instrumentation Revenue by Testing Throughput (2021-2026) & ($ million)
Table 25. Global Infectious Disease Testing Instrumentation Revenue Market Share by Testing Throughput (2021-2026)
Table 26. Global Infectious Disease Testing Instrumentation Sale Price by Testing Throughput (2021-2026) & (K USD/Unit)
Table 27. Global Infectious Disease Testing Instrumentation Sale by Application (2021-2026) & (K Units)
Table 28. Global Infectious Disease Testing Instrumentation Sale Market Share by Application (2021-2026)
Table 29. Global Infectious Disease Testing Instrumentation Revenue by Application (2021-2026) & ($ million)
Table 30. Global Infectious Disease Testing Instrumentation Revenue Market Share by Application (2021-2026)
Table 31. Global Infectious Disease Testing Instrumentation Sale Price by Application (2021-2026) & (K USD/Unit)
Table 32. Global Infectious Disease Testing Instrumentation Sales by Company (2021-2026) & (K Units)
Table 33. Global Infectious Disease Testing Instrumentation Sales Market Share by Company (2021-2026)
Table 34. Global Infectious Disease Testing Instrumentation Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Infectious Disease Testing Instrumentation Revenue Market Share by Company (2021-2026)
Table 36. Global Infectious Disease Testing Instrumentation Sale Price by Company (2021-2026) & (K USD/Unit)
Table 37. Key Manufacturers Infectious Disease Testing Instrumentation Producing Area Distribution and Sales Area
Table 38. Players Infectious Disease Testing Instrumentation Products Offered
Table 39. Infectious Disease Testing Instrumentation Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Infectious Disease Testing Instrumentation Sales by Geographic Region (2021-2026) & (K Units)
Table 43. Global Infectious Disease Testing Instrumentation Sales Market Share Geographic Region (2021-2026)
Table 44. Global Infectious Disease Testing Instrumentation Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Infectious Disease Testing Instrumentation Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Infectious Disease Testing Instrumentation Sales by Country/Region (2021-2026) & (K Units)
Table 47. Global Infectious Disease Testing Instrumentation Sales Market Share by Country/Region (2021-2026)
Table 48. Global Infectious Disease Testing Instrumentation Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Infectious Disease Testing Instrumentation Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Infectious Disease Testing Instrumentation Sales by Country (2021-2026) & (K Units)
Table 51. Americas Infectious Disease Testing Instrumentation Sales Market Share by Country (2021-2026)
Table 52. Americas Infectious Disease Testing Instrumentation Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Infectious Disease Testing Instrumentation Sales by Type (2021-2026) & (K Units)
Table 54. Americas Infectious Disease Testing Instrumentation Sales by Application (2021-2026) & (K Units)
Table 55. APAC Infectious Disease Testing Instrumentation Sales by Region (2021-2026) & (K Units)
Table 56. APAC Infectious Disease Testing Instrumentation Sales Market Share by Region (2021-2026)
Table 57. APAC Infectious Disease Testing Instrumentation Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Infectious Disease Testing Instrumentation Sales by Type (2021-2026) & (K Units)
Table 59. APAC Infectious Disease Testing Instrumentation Sales by Application (2021-2026) & (K Units)
Table 60. Europe Infectious Disease Testing Instrumentation Sales by Country (2021-2026) & (K Units)
Table 61. Europe Infectious Disease Testing Instrumentation Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Infectious Disease Testing Instrumentation Sales by Type (2021-2026) & (K Units)
Table 63. Europe Infectious Disease Testing Instrumentation Sales by Application (2021-2026) & (K Units)
Table 64. Middle East & Africa Infectious Disease Testing Instrumentation Sales by Country (2021-2026) & (K Units)
Table 65. Middle East & Africa Infectious Disease Testing Instrumentation Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Infectious Disease Testing Instrumentation Sales by Type (2021-2026) & (K Units)
Table 67. Middle East & Africa Infectious Disease Testing Instrumentation Sales by Application (2021-2026) & (K Units)
Table 68. Key Market Drivers & Growth Opportunities of Infectious Disease Testing Instrumentation
Table 69. Key Market Challenges & Risks of Infectious Disease Testing Instrumentation
Table 70. Key Industry Trends of Infectious Disease Testing Instrumentation
Table 71. Infectious Disease Testing Instrumentation Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Infectious Disease Testing Instrumentation Distributors List
Table 74. Infectious Disease Testing Instrumentation Customer List
Table 75. Global Infectious Disease Testing Instrumentation Sales Forecast by Region (2027-2032) & (K Units)
Table 76. Global Infectious Disease Testing Instrumentation Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Infectious Disease Testing Instrumentation Sales Forecast by Country (2027-2032) & (K Units)
Table 78. Americas Infectious Disease Testing Instrumentation Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Infectious Disease Testing Instrumentation Sales Forecast by Region (2027-2032) & (K Units)
Table 80. APAC Infectious Disease Testing Instrumentation Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Infectious Disease Testing Instrumentation Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Europe Infectious Disease Testing Instrumentation Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Infectious Disease Testing Instrumentation Sales Forecast by Country (2027-2032) & (K Units)
Table 84. Middle East & Africa Infectious Disease Testing Instrumentation Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Infectious Disease Testing Instrumentation Sales Forecast by Type (2027-2032) & (K Units)
Table 86. Global Infectious Disease Testing Instrumentation Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Infectious Disease Testing Instrumentation Sales Forecast by Application (2027-2032) & (K Units)
Table 88. Global Infectious Disease Testing Instrumentation Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Roche Diagnostics Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 90. Roche Diagnostics Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 91. Roche Diagnostics Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 92. Roche Diagnostics Main Business
Table 93. Roche Diagnostics Latest Developments
Table 94. Abbott Laboratories Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 95. Abbott Laboratories Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 96. Abbott Laboratories Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 97. Abbott Laboratories Main Business
Table 98. Abbott Laboratories Latest Developments
Table 99. BD Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 100. BD Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 101. BD Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 102. BD Main Business
Table 103. BD Latest Developments
Table 104. bioM?rieux Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 105. bioM?rieux Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 106. bioM?rieux Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 107. bioM?rieux Main Business
Table 108. bioM?rieux Latest Developments
Table 109. Danaher Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 110. Danaher Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 111. Danaher Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 112. Danaher Main Business
Table 113. Danaher Latest Developments
Table 114. QIAGEN Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 115. QIAGEN Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 116. QIAGEN Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 117. QIAGEN Main Business
Table 118. QIAGEN Latest Developments
Table 119. Hologic Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 120. Hologic Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 121. Hologic Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 122. Hologic Main Business
Table 123. Hologic Latest Developments
Table 124. DiaSorin Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 125. DiaSorin Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 126. DiaSorin Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 127. DiaSorin Main Business
Table 128. DiaSorin Latest Developments
Table 129. QuidelOrtho Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 130. QuidelOrtho Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 131. QuidelOrtho Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 132. QuidelOrtho Main Business
Table 133. QuidelOrtho Latest Developments
Table 134. Siemens Healthineers Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 135. Siemens Healthineers Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 136. Siemens Healthineers Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 137. Siemens Healthineers Main Business
Table 138. Siemens Healthineers Latest Developments
Table 139. Thermo Fisher Scientific Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 140. Thermo Fisher Scientific Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 141. Thermo Fisher Scientific Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 142. Thermo Fisher Scientific Main Business
Table 143. Thermo Fisher Scientific Latest Developments
Table 144. Bio-Rad Laboratories Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 145. Bio-Rad Laboratories Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 146. Bio-Rad Laboratories Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 147. Bio-Rad Laboratories Main Business
Table 148. Bio-Rad Laboratories Latest Developments
Table 149. Sansure Biotech Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 150. Sansure Biotech Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 151. Sansure Biotech Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 152. Sansure Biotech Main Business
Table 153. Sansure Biotech Latest Developments
Table 154. Daan Gene Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 155. Daan Gene Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 156. Daan Gene Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 157. Daan Gene Main Business
Table 158. Daan Gene Latest Developments
Table 159. Jiangsu Bioperfectus Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 160. Jiangsu Bioperfectus Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 161. Jiangsu Bioperfectus Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 162. Jiangsu Bioperfectus Main Business
Table 163. Jiangsu Bioperfectus Latest Developments
Table 164. Autobio Diagnostics Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 165. Autobio Diagnostics Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 166. Autobio Diagnostics Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 167. Autobio Diagnostics Main Business
Table 168. Autobio Diagnostics Latest Developments
Table 169. Snibe Diagnostic Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 170. Snibe Diagnostic Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 171. Snibe Diagnostic Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 172. Snibe Diagnostic Main Business
Table 173. Snibe Diagnostic Latest Developments
Table 174. Guangzhou Wondfo Biotech Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 175. Guangzhou Wondfo Biotech Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 176. Guangzhou Wondfo Biotech Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 177. Guangzhou Wondfo Biotech Main Business
Table 178. Guangzhou Wondfo Biotech Latest Developments
Table 1. Infectious Disease Testing Instrumentation Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Infectious Disease Testing Instrumentation Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Molecular Diagnostic Instruments
Table 4. Major Players of Immunoassay Analyzers
Table 5. Major Players of Microbiology Diagnostic Instruments
Table 6. Major Players of Other
Table 7. Global Infectious Disease Testing Instrumentation Sales by Type (2021-2026) & (K Units)
Table 8. Global Infectious Disease Testing Instrumentation Sales Market Share by Type (2021-2026)
Table 9. Global Infectious Disease Testing Instrumentation Revenue by Type (2021-2026) & ($ million)
Table 10. Global Infectious Disease Testing Instrumentation Revenue Market Share by Type (2021-2026)
Table 11. Global Infectious Disease Testing Instrumentation Sale Price by Type (2021-2026) & (K USD/Unit)
Table 12. Major Players of Fully Automated Systems
Table 13. Major Players of Semi-Automated Systems
Table 14. Global Infectious Disease Testing Instrumentation Sales by Automation Level (2021-2026) & (K Units)
Table 15. Global Infectious Disease Testing Instrumentation Sales Market Share by Automation Level (2021-2026)
Table 16. Global Infectious Disease Testing Instrumentation Revenue by Automation Level (2021-2026) & ($ million)
Table 17. Global Infectious Disease Testing Instrumentation Revenue Market Share by Automation Level (2021-2026)
Table 18. Global Infectious Disease Testing Instrumentation Sale Price by Automation Level (2021-2026) & (K USD/Unit)
Table 19. Major Players of Low-throughput Systems
Table 20. Major Players of Medium-throughput Systems
Table 21. Major Players of High-throughput Systems
Table 22. Global Infectious Disease Testing Instrumentation Sales by Testing Throughput (2021-2026) & (K Units)
Table 23. Global Infectious Disease Testing Instrumentation Sales Market Share by Testing Throughput (2021-2026)
Table 24. Global Infectious Disease Testing Instrumentation Revenue by Testing Throughput (2021-2026) & ($ million)
Table 25. Global Infectious Disease Testing Instrumentation Revenue Market Share by Testing Throughput (2021-2026)
Table 26. Global Infectious Disease Testing Instrumentation Sale Price by Testing Throughput (2021-2026) & (K USD/Unit)
Table 27. Global Infectious Disease Testing Instrumentation Sale by Application (2021-2026) & (K Units)
Table 28. Global Infectious Disease Testing Instrumentation Sale Market Share by Application (2021-2026)
Table 29. Global Infectious Disease Testing Instrumentation Revenue by Application (2021-2026) & ($ million)
Table 30. Global Infectious Disease Testing Instrumentation Revenue Market Share by Application (2021-2026)
Table 31. Global Infectious Disease Testing Instrumentation Sale Price by Application (2021-2026) & (K USD/Unit)
Table 32. Global Infectious Disease Testing Instrumentation Sales by Company (2021-2026) & (K Units)
Table 33. Global Infectious Disease Testing Instrumentation Sales Market Share by Company (2021-2026)
Table 34. Global Infectious Disease Testing Instrumentation Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Infectious Disease Testing Instrumentation Revenue Market Share by Company (2021-2026)
Table 36. Global Infectious Disease Testing Instrumentation Sale Price by Company (2021-2026) & (K USD/Unit)
Table 37. Key Manufacturers Infectious Disease Testing Instrumentation Producing Area Distribution and Sales Area
Table 38. Players Infectious Disease Testing Instrumentation Products Offered
Table 39. Infectious Disease Testing Instrumentation Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Infectious Disease Testing Instrumentation Sales by Geographic Region (2021-2026) & (K Units)
Table 43. Global Infectious Disease Testing Instrumentation Sales Market Share Geographic Region (2021-2026)
Table 44. Global Infectious Disease Testing Instrumentation Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Infectious Disease Testing Instrumentation Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Infectious Disease Testing Instrumentation Sales by Country/Region (2021-2026) & (K Units)
Table 47. Global Infectious Disease Testing Instrumentation Sales Market Share by Country/Region (2021-2026)
Table 48. Global Infectious Disease Testing Instrumentation Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Infectious Disease Testing Instrumentation Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Infectious Disease Testing Instrumentation Sales by Country (2021-2026) & (K Units)
Table 51. Americas Infectious Disease Testing Instrumentation Sales Market Share by Country (2021-2026)
Table 52. Americas Infectious Disease Testing Instrumentation Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Infectious Disease Testing Instrumentation Sales by Type (2021-2026) & (K Units)
Table 54. Americas Infectious Disease Testing Instrumentation Sales by Application (2021-2026) & (K Units)
Table 55. APAC Infectious Disease Testing Instrumentation Sales by Region (2021-2026) & (K Units)
Table 56. APAC Infectious Disease Testing Instrumentation Sales Market Share by Region (2021-2026)
Table 57. APAC Infectious Disease Testing Instrumentation Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Infectious Disease Testing Instrumentation Sales by Type (2021-2026) & (K Units)
Table 59. APAC Infectious Disease Testing Instrumentation Sales by Application (2021-2026) & (K Units)
Table 60. Europe Infectious Disease Testing Instrumentation Sales by Country (2021-2026) & (K Units)
Table 61. Europe Infectious Disease Testing Instrumentation Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Infectious Disease Testing Instrumentation Sales by Type (2021-2026) & (K Units)
Table 63. Europe Infectious Disease Testing Instrumentation Sales by Application (2021-2026) & (K Units)
Table 64. Middle East & Africa Infectious Disease Testing Instrumentation Sales by Country (2021-2026) & (K Units)
Table 65. Middle East & Africa Infectious Disease Testing Instrumentation Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Infectious Disease Testing Instrumentation Sales by Type (2021-2026) & (K Units)
Table 67. Middle East & Africa Infectious Disease Testing Instrumentation Sales by Application (2021-2026) & (K Units)
Table 68. Key Market Drivers & Growth Opportunities of Infectious Disease Testing Instrumentation
Table 69. Key Market Challenges & Risks of Infectious Disease Testing Instrumentation
Table 70. Key Industry Trends of Infectious Disease Testing Instrumentation
Table 71. Infectious Disease Testing Instrumentation Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Infectious Disease Testing Instrumentation Distributors List
Table 74. Infectious Disease Testing Instrumentation Customer List
Table 75. Global Infectious Disease Testing Instrumentation Sales Forecast by Region (2027-2032) & (K Units)
Table 76. Global Infectious Disease Testing Instrumentation Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Infectious Disease Testing Instrumentation Sales Forecast by Country (2027-2032) & (K Units)
Table 78. Americas Infectious Disease Testing Instrumentation Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Infectious Disease Testing Instrumentation Sales Forecast by Region (2027-2032) & (K Units)
Table 80. APAC Infectious Disease Testing Instrumentation Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Infectious Disease Testing Instrumentation Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Europe Infectious Disease Testing Instrumentation Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Infectious Disease Testing Instrumentation Sales Forecast by Country (2027-2032) & (K Units)
Table 84. Middle East & Africa Infectious Disease Testing Instrumentation Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Infectious Disease Testing Instrumentation Sales Forecast by Type (2027-2032) & (K Units)
Table 86. Global Infectious Disease Testing Instrumentation Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Infectious Disease Testing Instrumentation Sales Forecast by Application (2027-2032) & (K Units)
Table 88. Global Infectious Disease Testing Instrumentation Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Roche Diagnostics Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 90. Roche Diagnostics Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 91. Roche Diagnostics Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 92. Roche Diagnostics Main Business
Table 93. Roche Diagnostics Latest Developments
Table 94. Abbott Laboratories Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 95. Abbott Laboratories Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 96. Abbott Laboratories Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 97. Abbott Laboratories Main Business
Table 98. Abbott Laboratories Latest Developments
Table 99. BD Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 100. BD Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 101. BD Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 102. BD Main Business
Table 103. BD Latest Developments
Table 104. bioM?rieux Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 105. bioM?rieux Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 106. bioM?rieux Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 107. bioM?rieux Main Business
Table 108. bioM?rieux Latest Developments
Table 109. Danaher Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 110. Danaher Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 111. Danaher Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 112. Danaher Main Business
Table 113. Danaher Latest Developments
Table 114. QIAGEN Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 115. QIAGEN Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 116. QIAGEN Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 117. QIAGEN Main Business
Table 118. QIAGEN Latest Developments
Table 119. Hologic Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 120. Hologic Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 121. Hologic Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 122. Hologic Main Business
Table 123. Hologic Latest Developments
Table 124. DiaSorin Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 125. DiaSorin Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 126. DiaSorin Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 127. DiaSorin Main Business
Table 128. DiaSorin Latest Developments
Table 129. QuidelOrtho Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 130. QuidelOrtho Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 131. QuidelOrtho Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 132. QuidelOrtho Main Business
Table 133. QuidelOrtho Latest Developments
Table 134. Siemens Healthineers Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 135. Siemens Healthineers Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 136. Siemens Healthineers Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 137. Siemens Healthineers Main Business
Table 138. Siemens Healthineers Latest Developments
Table 139. Thermo Fisher Scientific Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 140. Thermo Fisher Scientific Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 141. Thermo Fisher Scientific Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 142. Thermo Fisher Scientific Main Business
Table 143. Thermo Fisher Scientific Latest Developments
Table 144. Bio-Rad Laboratories Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 145. Bio-Rad Laboratories Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 146. Bio-Rad Laboratories Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 147. Bio-Rad Laboratories Main Business
Table 148. Bio-Rad Laboratories Latest Developments
Table 149. Sansure Biotech Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 150. Sansure Biotech Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 151. Sansure Biotech Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 152. Sansure Biotech Main Business
Table 153. Sansure Biotech Latest Developments
Table 154. Daan Gene Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 155. Daan Gene Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 156. Daan Gene Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 157. Daan Gene Main Business
Table 158. Daan Gene Latest Developments
Table 159. Jiangsu Bioperfectus Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 160. Jiangsu Bioperfectus Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 161. Jiangsu Bioperfectus Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 162. Jiangsu Bioperfectus Main Business
Table 163. Jiangsu Bioperfectus Latest Developments
Table 164. Autobio Diagnostics Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 165. Autobio Diagnostics Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 166. Autobio Diagnostics Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 167. Autobio Diagnostics Main Business
Table 168. Autobio Diagnostics Latest Developments
Table 169. Snibe Diagnostic Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 170. Snibe Diagnostic Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 171. Snibe Diagnostic Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 172. Snibe Diagnostic Main Business
Table 173. Snibe Diagnostic Latest Developments
Table 174. Guangzhou Wondfo Biotech Basic Information, Infectious Disease Testing Instrumentation Manufacturing Base, Sales Area and Its Competitors
Table 175. Guangzhou Wondfo Biotech Infectious Disease Testing Instrumentation Product Portfolios and Specifications
Table 176. Guangzhou Wondfo Biotech Infectious Disease Testing Instrumentation Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2021-2026)
Table 177. Guangzhou Wondfo Biotech Main Business
Table 178. Guangzhou Wondfo Biotech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Infectious Disease Testing Instrumentation
Figure 2. Infectious Disease Testing Instrumentation Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Infectious Disease Testing Instrumentation Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Infectious Disease Testing Instrumentation Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Infectious Disease Testing Instrumentation Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Infectious Disease Testing Instrumentation Sales Market Share by Country/Region (2025)
Figure 10. Infectious Disease Testing Instrumentation Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Molecular Diagnostic Instruments
Figure 12. Product Picture of Immunoassay Analyzers
Figure 13. Product Picture of Microbiology Diagnostic Instruments
Figure 14. Product Picture of Other
Figure 15. Global Infectious Disease Testing Instrumentation Sales Market Share by Type in 2026
Figure 16. Global Infectious Disease Testing Instrumentation Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Fully Automated Systems
Figure 18. Product Picture of Semi-Automated Systems
Figure 19. Global Infectious Disease Testing Instrumentation Sales Market Share by Automation Level in 2026
Figure 20. Global Infectious Disease Testing Instrumentation Revenue Market Share by Automation Level (2021-2026)
Figure 21. Product Picture of Low-throughput Systems
Figure 22. Product Picture of Medium-throughput Systems
Figure 23. Product Picture of High-throughput Systems
Figure 24. Global Infectious Disease Testing Instrumentation Sales Market Share by Testing Throughput in 2026
Figure 25. Global Infectious Disease Testing Instrumentation Revenue Market Share by Testing Throughput (2021-2026)
Figure 26. Infectious Disease Testing Instrumentation Consumed in Hospital & Clinic
Figure 27. Global Infectious Disease Testing Instrumentation Market: Hospital & Clinic (2021-2026) & (K Units)
Figure 28. Infectious Disease Testing Instrumentation Consumed in Laboratory
Figure 29. Global Infectious Disease Testing Instrumentation Market: Laboratory (2021-2026) & (K Units)
Figure 30. Infectious Disease Testing Instrumentation Consumed in Other
Figure 31. Global Infectious Disease Testing Instrumentation Market: Other (2021-2026) & (K Units)
Figure 32. Global Infectious Disease Testing Instrumentation Sale Market Share by Application (2025)
Figure 33. Global Infectious Disease Testing Instrumentation Revenue Market Share by Application in 2025
Figure 34. Infectious Disease Testing Instrumentation Sales by Company in 2025 (K Units)
Figure 35. Global Infectious Disease Testing Instrumentation Sales Market Share by Company in 2025
Figure 36. Infectious Disease Testing Instrumentation Revenue by Company in 2025 ($ millions)
Figure 37. Global Infectious Disease Testing Instrumentation Revenue Market Share by Company in 2025
Figure 38. Global Infectious Disease Testing Instrumentation Sales Market Share by Geographic Region (2021-2026)
Figure 39. Global Infectious Disease Testing Instrumentation Revenue Market Share by Geographic Region in 2025
Figure 40. Americas Infectious Disease Testing Instrumentation Sales 2021-2026 (K Units)
Figure 41. Americas Infectious Disease Testing Instrumentation Revenue 2021-2026 ($ millions)
Figure 42. APAC Infectious Disease Testing Instrumentation Sales 2021-2026 (K Units)
Figure 43. APAC Infectious Disease Testing Instrumentation Revenue 2021-2026 ($ millions)
Figure 44. Europe Infectious Disease Testing Instrumentation Sales 2021-2026 (K Units)
Figure 45. Europe Infectious Disease Testing Instrumentation Revenue 2021-2026 ($ millions)
Figure 46. Middle East & Africa Infectious Disease Testing Instrumentation Sales 2021-2026 (K Units)
Figure 47. Middle East & Africa Infectious Disease Testing Instrumentation Revenue 2021-2026 ($ millions)
Figure 48. Americas Infectious Disease Testing Instrumentation Sales Market Share by Country in 2025
Figure 49. Americas Infectious Disease Testing Instrumentation Revenue Market Share by Country (2021-2026)
Figure 50. Americas Infectious Disease Testing Instrumentation Sales Market Share by Type (2021-2026)
Figure 51. Americas Infectious Disease Testing Instrumentation Sales Market Share by Application (2021-2026)
Figure 52. United States Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 53. Canada Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 54. Mexico Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 55. Brazil Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 56. APAC Infectious Disease Testing Instrumentation Sales Market Share by Region in 2025
Figure 57. APAC Infectious Disease Testing Instrumentation Revenue Market Share by Region (2021-2026)
Figure 58. APAC Infectious Disease Testing Instrumentation Sales Market Share by Type (2021-2026)
Figure 59. APAC Infectious Disease Testing Instrumentation Sales Market Share by Application (2021-2026)
Figure 60. China Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 61. Japan Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 62. South Korea Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 63. Southeast Asia Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 64. India Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 65. Australia Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 66. China Taiwan Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 67. Europe Infectious Disease Testing Instrumentation Sales Market Share by Country in 2025
Figure 68. Europe Infectious Disease Testing Instrumentation Revenue Market Share by Country (2021-2026)
Figure 69. Europe Infectious Disease Testing Instrumentation Sales Market Share by Type (2021-2026)
Figure 70. Europe Infectious Disease Testing Instrumentation Sales Market Share by Application (2021-2026)
Figure 71. Germany Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 72. France Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 73. UK Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 74. Italy Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 75. Russia Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 76. Middle East & Africa Infectious Disease Testing Instrumentation Sales Market Share by Country (2021-2026)
Figure 77. Middle East & Africa Infectious Disease Testing Instrumentation Sales Market Share by Type (2021-2026)
Figure 78. Middle East & Africa Infectious Disease Testing Instrumentation Sales Market Share by Application (2021-2026)
Figure 79. Egypt Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 80. South Africa Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 81. Israel Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 82. Turkey Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 83. GCC Countries Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of Infectious Disease Testing Instrumentation in 2026
Figure 85. Manufacturing Process Analysis of Infectious Disease Testing Instrumentation
Figure 86. Industry Chain Structure of Infectious Disease Testing Instrumentation
Figure 87. Channels of Distribution
Figure 88. Global Infectious Disease Testing Instrumentation Sales Market Forecast by Region (2027-2032)
Figure 89. Global Infectious Disease Testing Instrumentation Revenue Market Share Forecast by Region (2027-2032)
Figure 90. Global Infectious Disease Testing Instrumentation Sales Market Share Forecast by Type (2027-2032)
Figure 91. Global Infectious Disease Testing Instrumentation Revenue Market Share Forecast by Type (2027-2032)
Figure 92. Global Infectious Disease Testing Instrumentation Sales Market Share Forecast by Application (2027-2032)
Figure 93. Global Infectious Disease Testing Instrumentation Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Infectious Disease Testing Instrumentation
Figure 2. Infectious Disease Testing Instrumentation Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Infectious Disease Testing Instrumentation Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Infectious Disease Testing Instrumentation Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Infectious Disease Testing Instrumentation Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Infectious Disease Testing Instrumentation Sales Market Share by Country/Region (2025)
Figure 10. Infectious Disease Testing Instrumentation Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Molecular Diagnostic Instruments
Figure 12. Product Picture of Immunoassay Analyzers
Figure 13. Product Picture of Microbiology Diagnostic Instruments
Figure 14. Product Picture of Other
Figure 15. Global Infectious Disease Testing Instrumentation Sales Market Share by Type in 2026
Figure 16. Global Infectious Disease Testing Instrumentation Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Fully Automated Systems
Figure 18. Product Picture of Semi-Automated Systems
Figure 19. Global Infectious Disease Testing Instrumentation Sales Market Share by Automation Level in 2026
Figure 20. Global Infectious Disease Testing Instrumentation Revenue Market Share by Automation Level (2021-2026)
Figure 21. Product Picture of Low-throughput Systems
Figure 22. Product Picture of Medium-throughput Systems
Figure 23. Product Picture of High-throughput Systems
Figure 24. Global Infectious Disease Testing Instrumentation Sales Market Share by Testing Throughput in 2026
Figure 25. Global Infectious Disease Testing Instrumentation Revenue Market Share by Testing Throughput (2021-2026)
Figure 26. Infectious Disease Testing Instrumentation Consumed in Hospital & Clinic
Figure 27. Global Infectious Disease Testing Instrumentation Market: Hospital & Clinic (2021-2026) & (K Units)
Figure 28. Infectious Disease Testing Instrumentation Consumed in Laboratory
Figure 29. Global Infectious Disease Testing Instrumentation Market: Laboratory (2021-2026) & (K Units)
Figure 30. Infectious Disease Testing Instrumentation Consumed in Other
Figure 31. Global Infectious Disease Testing Instrumentation Market: Other (2021-2026) & (K Units)
Figure 32. Global Infectious Disease Testing Instrumentation Sale Market Share by Application (2025)
Figure 33. Global Infectious Disease Testing Instrumentation Revenue Market Share by Application in 2025
Figure 34. Infectious Disease Testing Instrumentation Sales by Company in 2025 (K Units)
Figure 35. Global Infectious Disease Testing Instrumentation Sales Market Share by Company in 2025
Figure 36. Infectious Disease Testing Instrumentation Revenue by Company in 2025 ($ millions)
Figure 37. Global Infectious Disease Testing Instrumentation Revenue Market Share by Company in 2025
Figure 38. Global Infectious Disease Testing Instrumentation Sales Market Share by Geographic Region (2021-2026)
Figure 39. Global Infectious Disease Testing Instrumentation Revenue Market Share by Geographic Region in 2025
Figure 40. Americas Infectious Disease Testing Instrumentation Sales 2021-2026 (K Units)
Figure 41. Americas Infectious Disease Testing Instrumentation Revenue 2021-2026 ($ millions)
Figure 42. APAC Infectious Disease Testing Instrumentation Sales 2021-2026 (K Units)
Figure 43. APAC Infectious Disease Testing Instrumentation Revenue 2021-2026 ($ millions)
Figure 44. Europe Infectious Disease Testing Instrumentation Sales 2021-2026 (K Units)
Figure 45. Europe Infectious Disease Testing Instrumentation Revenue 2021-2026 ($ millions)
Figure 46. Middle East & Africa Infectious Disease Testing Instrumentation Sales 2021-2026 (K Units)
Figure 47. Middle East & Africa Infectious Disease Testing Instrumentation Revenue 2021-2026 ($ millions)
Figure 48. Americas Infectious Disease Testing Instrumentation Sales Market Share by Country in 2025
Figure 49. Americas Infectious Disease Testing Instrumentation Revenue Market Share by Country (2021-2026)
Figure 50. Americas Infectious Disease Testing Instrumentation Sales Market Share by Type (2021-2026)
Figure 51. Americas Infectious Disease Testing Instrumentation Sales Market Share by Application (2021-2026)
Figure 52. United States Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 53. Canada Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 54. Mexico Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 55. Brazil Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 56. APAC Infectious Disease Testing Instrumentation Sales Market Share by Region in 2025
Figure 57. APAC Infectious Disease Testing Instrumentation Revenue Market Share by Region (2021-2026)
Figure 58. APAC Infectious Disease Testing Instrumentation Sales Market Share by Type (2021-2026)
Figure 59. APAC Infectious Disease Testing Instrumentation Sales Market Share by Application (2021-2026)
Figure 60. China Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 61. Japan Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 62. South Korea Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 63. Southeast Asia Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 64. India Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 65. Australia Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 66. China Taiwan Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 67. Europe Infectious Disease Testing Instrumentation Sales Market Share by Country in 2025
Figure 68. Europe Infectious Disease Testing Instrumentation Revenue Market Share by Country (2021-2026)
Figure 69. Europe Infectious Disease Testing Instrumentation Sales Market Share by Type (2021-2026)
Figure 70. Europe Infectious Disease Testing Instrumentation Sales Market Share by Application (2021-2026)
Figure 71. Germany Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 72. France Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 73. UK Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 74. Italy Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 75. Russia Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 76. Middle East & Africa Infectious Disease Testing Instrumentation Sales Market Share by Country (2021-2026)
Figure 77. Middle East & Africa Infectious Disease Testing Instrumentation Sales Market Share by Type (2021-2026)
Figure 78. Middle East & Africa Infectious Disease Testing Instrumentation Sales Market Share by Application (2021-2026)
Figure 79. Egypt Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 80. South Africa Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 81. Israel Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 82. Turkey Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 83. GCC Countries Infectious Disease Testing Instrumentation Revenue Growth 2021-2026 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of Infectious Disease Testing Instrumentation in 2026
Figure 85. Manufacturing Process Analysis of Infectious Disease Testing Instrumentation
Figure 86. Industry Chain Structure of Infectious Disease Testing Instrumentation
Figure 87. Channels of Distribution
Figure 88. Global Infectious Disease Testing Instrumentation Sales Market Forecast by Region (2027-2032)
Figure 89. Global Infectious Disease Testing Instrumentation Revenue Market Share Forecast by Region (2027-2032)
Figure 90. Global Infectious Disease Testing Instrumentation Sales Market Share Forecast by Type (2027-2032)
Figure 91. Global Infectious Disease Testing Instrumentation Revenue Market Share Forecast by Type (2027-2032)
Figure 92. Global Infectious Disease Testing Instrumentation Sales Market Share Forecast by Application (2027-2032)
Figure 93. Global Infectious Disease Testing Instrumentation Revenue Market Share Forecast by Application (2027-2032)
